Pharmaceutical Laboratories, Inc. (OTC BB:PHLB), a leader in nutriceuticals with advanced liquid nutritional products, today announced that the Company is launching its Liquid Solutions Sports Line of products for improved sports performance.
The new Sports Line consists of six individually packaged products - Creatine for the muscles, Minerals for electrolytes, Ginseng for stamina, MSM for reduced pain in joints and muscles, L-Arginine for muscle mass, and B-Total solution for energy. The six products can be purchased separately for a total of $69.75 or in a special Value Pack for $59.75.
"In my opinion, there is not a better value to be found. We fully expect this new line to emerge as the performance product of choice for the millions of athletes who want the best in nutrition," stated president and chief executive officer of PHLB Jerry M McClure.
The nutritional products industry is currently $9.8 billion and growing. PHLB is committed to increasing its market share by remaining the leader in liquid nutritional technology.
McClure went on to say, "I spent almost ten years as a professional athlete and I have never seen any products like these. Mixed together in 10 oz. of water and taken approximately one hour before workout, they can create amazing results."
Pharmaceutical Laboratories, Inc. specializes in the development, manufacturing, and marketing of liquid vitamin and nutritional products in the U.S. and abroad. The Company's products are manufactured at its on-site production facilities under strict quality standards, with each batch tested for potency, purity, and stability to guarantee the accuracy of its label claims.
For further information, see www.otcfn.com/phlb and www.phlb.com.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, includingg without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
- SOURCE : Business Wire1999.06.28
|
Newsdesk